Phase II clinical research design in cardiology learning the right lessons too well: Observations and recommendations from the cardiovascular cell therapy research network (CCTRN)

Joshua M. Hare, Roberto Bolli, John P. Cooke, David J. Gordon, Timothy D. Henry, Emerson C. Perin, Keith L. March, Michael P. Murphy, Carl J. Pepine, Robert D. Simari, Sonia I. Skarlatos, Jay H. Traverse, James T. Willerson, Anita D. Szady, Doris A. Taylor, Rachel W. Vojvodic, Phillip C. Yang, Lemuel A. Moyé

Research output: Contribution to journalArticle

30 Scopus citations
Original languageEnglish (US)
Pages (from-to)1630-1635
Number of pages6
JournalCirculation
Volume127
Issue number15
DOIs
StatePublished - Apr 16 2013

Keywords

  • Clinical trials, phase II
  • Research design
  • Stem cell
  • Therapy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine
  • Physiology (medical)

Cite this

Hare, J. M., Bolli, R., Cooke, J. P., Gordon, D. J., Henry, T. D., Perin, E. C., March, K. L., Murphy, M. P., Pepine, C. J., Simari, R. D., Skarlatos, S. I., Traverse, J. H., Willerson, J. T., Szady, A. D., Taylor, D. A., Vojvodic, R. W., Yang, P. C., & Moyé, L. A. (2013). Phase II clinical research design in cardiology learning the right lessons too well: Observations and recommendations from the cardiovascular cell therapy research network (CCTRN). Circulation, 127(15), 1630-1635. https://doi.org/10.1161/CIRCULATIONAHA.112.000779